Knight Therapeutics Inc.
Knight Therapeutics Inc. (GUD.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GUD.TO · as of Jun 8, 2026
Key Statistics
Explore Knight Therapeutics Inc. Data
gud.to stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
gud.to competitorsGUD.TO
ACB.TO
CL.CN
CPH.TO
DRUG.CN
KSI.TOStock Performance
Full HistoryAbout Knight Therapeutics Inc.
Knight Therapeutics Inc. a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices i…
what is knight therapeutics inc. · gud.to stock overview · knight therapeutics inc. company profile · who is knight therapeutics inc. ceo · gud.to TSX · knight therapeutics inc. headquarters · knight therapeutics inc. business segments
About Stock Overview & Key Data
Knight Therapeutics Inc. (GUD.TO) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on TSX since Mar 3, 2014. As of the latest trading session, GUD.TO stock price is $8.61, with a market capitalization of $844.1M. The stock has returned +43.02% over the past 12 months and +42.31% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Knight Therapeutics Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Knight Therapeutics Inc. reported revenue of $450.1M and net income of -$5.4M. For detailed data — including Knight Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Knight Therapeutics Inc. (GUD.TO) stock price is $8.61. The stock is traded on TSX under the ticker symbol GUD.TO. The 52-week range is $5.66 – $8.90.